Peripheral Embolic Protection Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

Pages: 0 Published: May 10, 2022 Report Code: GDME671MM

Peripheral Embolic Protection Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Peripheral Embolic Protection Devices market for the year 2020 and beyond. A narrowing of arteries due to the build-up of plaque occurs in conditions such as peripheral vascular disease, carotid artery stenosis and renal artery stenosis. Angioplasty is a minimally invasive interventional procedure that is used to unblock an artery with excessive plaque build-up in order to restore normal blood flow. Embolic debris may become dislodged during angioplasty procedures, which if left alone can cause a pulmonary embolism. To protect against distal embolic events, EPD are designed to capture and remove debris that may get dislodged during interventional procedures. Present technologies for Embolic Protection Devices (EPD) employ three important strategies: distal occlusion, proximal occlusion and distal filtration.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are –

  • Currently marketed Peripheral Embolic Protection Devices market and evolving competitive landscape –
  • Insightful review of the key industry trends.
  • Annualized total Peripheral Embolic Protection Devices market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights –

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Peripheral Embolic Protection Devices market.
  • Competitive dynamics insights and trends provided Peripheral Embolic Protection Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Medtronic plc, Abbott Laboratories, Boston Scientific Corp, Cardinal Health Inc, Allium Medical Solutions Ltd

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope of the Peripheral Embolic Protection Devices market model

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Currently marketed Peripheral Embolic Protection Devices and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total peripheral embolic protection devices market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.
  • Global, Regional and Country level market specific insights include: Qualitative market specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for peripheral embolic protection devices market.
  • Competitive dynamics insights and trends provided for peripheral embolic protection devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

What is the Peripheral Embolic Protection Devices market size during the historical and forecast period?

Peripheral Embolic Protection Devices market, by segment

Peripheral Embolic Protection Devices market, by segment

For more segment insights, download a free report sample

What are the key trends within the Peripheral Embolic Protection Devices market?

GlobalData predicts that the overall peripheral embolic protection devices market will grow in North America across the forecast period. The carotid embolic protection device market is expected to increase throughout the forecast years, driven primarily due to improved outcomes after carotid artery stenosis treatment. EPDs help to prevent and decrease distal embolization in the carotid artery. Also, they reduce the chances of re-stenosis as by preventing the accumulation of debris in arteries.

According to Key opinion leaders (KOL), embolic protection devices must always be used in the carotid arteries. In the peripheral vessels (lower extremities), EPDs are seldom being used. In these cases, the likelihood of embolization is relatively low and the clinical consequences are less dangerous and in the cases of the lower extremity, are more easily treatable.

GlobalData predicts that the overall peripheral embolic protection devices market will grow in APAC across the forecast period. The carotid embolic protection device market will grow in this region due to the increasing volume of interventionally treated cases undergoing carotid artery angioplasty with EPD.

GlobalData predicts that the overall peripheral embolic protection devices market will grow in South & Central America across the forecast period.

Middle Eastern countries have shown increasing trends in the usage of tobacco, high fat calorie diets and sedentary lifestyles, which drives increased prevalence of PAD and carotid artery stenosis.

Peripheral Embolic Protection Devices market report scope

Market value (Year – 2021) $305.6 million
Segmentation by sector Carotid Embolic Protection Devices and Lower Extremity Embolic Protection Devices
Key companies Medtronic plc, Abbott Laboratories, Boston Scientific Corp, Cardinal Health Inc, Allium Medical Solutions Ltd
Regions covered North America, South & Central America, Europe, Middle East & Africa, Asia-Pacific
Countries covered United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile

Who are the Peripheral Embolic Protection Devices market vendors?

The model analyses the competitive landscape of the peripheral embolic protection devices market and includes information on the following key market vendors:

Medtronic plc, Abbott Laboratories, Boston Scientific Corp, Cardinal Health Inc, Allium Medical Solutions Ltd

Reasons to Buy

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

  • CMO executives who must have deep understanding of the peripheral embolic protection devices marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

The model will enable you to:

  • Understand the impact of COVID-19 on peripheral embolic protection devices market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving peripheral embolic protection devices market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the peripheral embolic protection devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific peripheral embolic protection devices market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Key Players

Medtronic plc

Abbott Laboratories

Boston Scientific Corp

Cardinal Health Inc

Allium Medical Solutions Ltd

Frequently Asked Questions

Request a Free Sample
$7500

Can be used by individual purchaser only

$22500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.